Back to Search Start Over

Secukinumab administration by a 2 mL autoinjector demonstrates high efficacy with comparable safety and tolerability in adult patients with plaque psoriasis: 16-week results from MATURE

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.od......2294..3eff018d64a4650b655c5c6eac783ee5